Successful treatment of glucocorticoid-resistant acute severe urticaria with JAK1 inhibitor: case report
{{output}}
Objective: This study analyzes a case with a JAK1 (Janus Kinase 1) inhibitor was successfully employed to treat a patient with glucocorticoid-resistant acute severe urticaria (ASU), with the aim of improving clinical understandin... ...
